-
1
-
-
0032771475
-
Nonalcoholic steatohepatitis
-
Diehl AM. Nonalcoholic steatohepatitis. Semin Liver Dis 1999; 19: 221-9.
-
(1999)
Semin Liver Dis
, vol.19
, pp. 221-229
-
-
Diehl, A.M.1
-
2
-
-
0037382786
-
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
-
Marchesini G, Bugianesi E, Forlani G et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-23.
-
(2003)
Hepatology
, vol.37
, pp. 917-923
-
-
Marchesini, G.1
Bugianesi, E.2
Forlani, G.3
-
3
-
-
18244385511
-
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
-
Pagano G, Pacini G, Musso G et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002; 35: 367-72.
-
(2002)
Hepatology
, vol.35
, pp. 367-372
-
-
Pagano, G.1
Pacini, G.2
Musso, G.3
-
4
-
-
0031947715
-
Steatohepatitis: A tale of two "hits"?
-
Day CP, James OF. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998; 114: 842-5.
-
(1998)
Gastroenterology
, vol.114
, pp. 842-845
-
-
Day, C.P.1
James, O.F.2
-
5
-
-
0038644536
-
Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
-
Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-19.
-
(2003)
Hepatology
, vol.37
, pp. 1202-1219
-
-
Neuschwander-Tetri, B.A.1
Caldwell, S.H.2
-
6
-
-
0032211577
-
Molecular regulation of hepatic fibrogenesis
-
Olaso E, Friedman SL. Molecular regulation of hepatic fibrogenesis. J Hepatol 1998; 29: 836-47.
-
(1998)
J Hepatol
, vol.29
, pp. 836-847
-
-
Olaso, E.1
Friedman, S.L.2
-
7
-
-
33746521801
-
Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
-
Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-35.
-
(1993)
N Engl J Med
, vol.328
, pp. 1828-1835
-
-
Friedman, S.L.1
-
8
-
-
0025000652
-
Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo
-
Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990; 86: 1641-8.
-
(1990)
J Clin Invest
, vol.86
, pp. 1641-1648
-
-
Maher, J.J.1
McGuire, R.F.2
-
9
-
-
0026519114
-
Lipocyte activation and hepatic fibrosis
-
Bissell DM. Lipocyte activation and hepatic fibrosis. Gastroenterology 1992; 102: 1803-5.
-
(1992)
Gastroenterology
, vol.102
, pp. 1803-1805
-
-
Bissell, D.M.1
-
11
-
-
27344454809
-
Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice
-
Tanaka T, Masuzaki H, Ebihara K et al. Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice. Metabolism 2005; 54: 1490-8.
-
(2005)
Metabolism
, vol.54
, pp. 1490-1498
-
-
Tanaka, T.1
Masuzaki, H.2
Ebihara, K.3
-
12
-
-
0037385387
-
Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis
-
Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Sponseller CA, Hampton K, Bacon BR. Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. J Hepatol 2003; 38: 434-40.
-
(2003)
J Hepatol
, vol.38
, pp. 434-440
-
-
Neuschwander-Tetri, B.A.1
Brunt, E.M.2
Wehmeier, K.R.3
Sponseller, C.A.4
Hampton, K.5
Bacon, B.R.6
-
13
-
-
0141532275
-
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone
-
Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone. Hepatology 2003; 38: 1008-17.
-
(2003)
Hepatology
, vol.38
, pp. 1008-1017
-
-
Neuschwander-Tetri, B.A.1
Brunt, E.M.2
Wehmeier, K.R.3
Oliver, D.4
Bacon, B.R.5
-
14
-
-
0033962940
-
Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells
-
Galli A, Crabb D, Price D et al. Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology 2000; 31: 101-8.
-
(2000)
Hepatology
, vol.31
, pp. 101-108
-
-
Galli, A.1
Crabb, D.2
Price, D.3
-
15
-
-
0033855572
-
Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells
-
Marra F, Efsen E, Romanelli RG et al. Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000; 119: 466-78.
-
(2000)
Gastroenterology
, vol.119
, pp. 466-478
-
-
Marra, F.1
Efsen, E.2
Romanelli, R.G.3
-
16
-
-
0036086754
-
Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride
-
Kon K, Ikejima K, Hirose M et al. Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem Biophys Res Commun 2002; 291: 55-61.
-
(2002)
Biochem Biophys Res Commun
, vol.291
, pp. 55-61
-
-
Kon, K.1
Ikejima, K.2
Hirose, M.3
-
17
-
-
0036082703
-
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro
-
Galli A, Crabb DW, Ceni E et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002; 122: 1924-40.
-
(2002)
Gastroenterology
, vol.122
, pp. 1924-1940
-
-
Galli, A.1
Crabb, D.W.2
Ceni, E.3
-
19
-
-
2442660528
-
Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease
-
Tenenbaum A, Motro M, Fisman EZ et al. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Circulation 2004; 109: 2197-202.
-
(2004)
Circulation
, vol.109
, pp. 2197-2202
-
-
Tenenbaum, A.1
Motro, M.2
Fisman, E.Z.3
-
20
-
-
33645738300
-
Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate
-
Tenenbaum A, Fisman EZ, Boyko V et al. Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate. Arch Intern Med 2006; 166: 737-41.
-
(2006)
Arch Intern Med
, vol.166
, pp. 737-741
-
-
Tenenbaum, A.1
Fisman, E.Z.2
Boyko, V.3
-
21
-
-
0033594768
-
Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis
-
Saibara T, Onishi S, Ogawa Y, Yoshida S, Enzan H. Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis. Lancet 1999; 353: 1802.
-
(1999)
Lancet
, vol.353
, pp. 1802
-
-
Saibara, T.1
Onishi, S.2
Ogawa, Y.3
Yoshida, S.4
Enzan, H.5
-
22
-
-
5144224821
-
PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats
-
Toyama T, Nakamura H, Harano Y et al. PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun 2004; 324: 697-704.
-
(2004)
Biochem Biophys Res Commun
, vol.324
, pp. 697-704
-
-
Toyama, T.1
Nakamura, H.2
Harano, Y.3
-
23
-
-
2342644813
-
Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice
-
Ip E, Farrell G, Hall P, Robertson G, Leclercq I etal. Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 2004; 39: 1286-96.
-
(2004)
Hepatology
, vol.39
, pp. 1286-1296
-
-
Ip, E.1
Farrell, G.2
Hall, P.3
Robertson, G.4
Leclercq, I.5
-
24
-
-
0242438087
-
Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis
-
George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 2003; 39: 756-64.
-
(2003)
J Hepatol
, vol.39
, pp. 756-764
-
-
George, J.1
Pera, N.2
Phung, N.3
Leclercq, I.4
Yun Hou, J.5
Farrell, G.6
-
25
-
-
0038643427
-
Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice
-
Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I. Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 2003; 38: 123-32.
-
(2003)
Hepatology
, vol.38
, pp. 123-132
-
-
Ip, E.1
Farrell, G.C.2
Robertson, G.3
Hall, P.4
Kirsch, R.5
Leclercq, I.6
-
26
-
-
4043170647
-
Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice
-
McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 2004; 40: 386-93.
-
(2004)
Hepatology
, vol.40
, pp. 386-393
-
-
McCuskey, R.S.1
Ito, Y.2
Robertson, G.R.3
McCuskey, M.K.4
Perry, M.5
Farrell, G.C.6
-
28
-
-
0029829455
-
Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
-
Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996; 111: 1645-53.
-
(1996)
Gastroenterology
, vol.111
, pp. 1645-1653
-
-
Weltman, M.D.1
Farrell, G.C.2
Liddle, C.3
-
29
-
-
70449158340
-
A simple method for the isolation and purification of total lipids from animal tissues
-
Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
-
(1957)
J Biol Chem
, vol.226
, pp. 497-509
-
-
Folch, J.1
Lees, M.2
Stanley, G.H.S.3
-
30
-
-
0033043662
-
SV40 large T antigen immortalization of rat hepatic stellate-like cells
-
Tokiwa T, Yata Y, Takahara T et al. SV40 large T antigen immortalization of rat hepatic stellate-like cells. In Vitro Cell Dev Biol Anim 1999; 35: 246-7.
-
(1999)
In Vitro Cell Dev Biol Anim
, vol.35
, pp. 246-247
-
-
Tokiwa, T.1
Yata, Y.2
Takahara, T.3
-
31
-
-
0032955139
-
Characterization of immortalized rat hepatic stellate cell lines transfected with SV40 T antigen
-
Yutaka Y, Tokiwa T, Takahara T, Zhang LP, Watanabe A. Characterization of immortalized rat hepatic stellate cell lines transfected with SV40 T antigen. Hepatol Res 1999; 14: 239-44.
-
(1999)
Hepatol Res
, vol.14
, pp. 239-244
-
-
Yutaka, Y.1
Tokiwa, T.2
Takahara, T.3
Zhang, L.P.4
Watanabe, A.5
-
32
-
-
33645891166
-
Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARä agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
-
Nagasawa T, Inada Y, Nakano S et al. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARä agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. Eur J Pharmacol 2006; 536: 182-91.
-
(2006)
Eur J Pharmacol
, vol.536
, pp. 182-191
-
-
Nagasawa, T.1
Inada, Y.2
Nakano, S.3
-
33
-
-
0038823617
-
Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation
-
Chavey C, Mari B, Monthouel MN et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003; 278: 11888-96.
-
(2003)
J Biol Chem
, vol.278
, pp. 11888-11896
-
-
Chavey, C.1
Mari, B.2
Monthouel, M.N.3
-
34
-
-
19544378172
-
The roles of leptin and adiponectin: A novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology
-
Ding X, Saxena NK, Lin S, Xu A, Srinivasan S, Anania FA. The roles of leptin and adiponectin: A novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol 2005; 166: 1655-69.
-
(2005)
Am J Pathol
, vol.166
, pp. 1655-1669
-
-
Ding, X.1
Saxena, N.K.2
Lin, S.3
Xu, A.4
Srinivasan, S.5
Anania, F.A.6
-
35
-
-
0141765849
-
Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia
-
Kuzuya M, Kanda S, Sasaki T et al. Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation 2003; 108: 1375-81.
-
(2003)
Circulation
, vol.108
, pp. 1375-1381
-
-
Kuzuya, M.1
Kanda, S.2
Sasaki, T.3
-
36
-
-
0037133240
-
Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice
-
Trogan E, Choudhury RP, Dansky HM, Rong JX, Breslow JL, Fisher EA. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 2003; 99: 2234-9.
-
(2003)
Proc Natl Acad Sci USA
, vol.99
, pp. 2234-2239
-
-
Trogan, E.1
Choudhury, R.P.2
Dansky, H.M.3
Rong, J.X.4
Breslow, J.L.5
Fisher, E.A.6
-
37
-
-
0029922002
-
Fibrates induce mdr2 gene expression and biliary phospholipids secretion in the mouse
-
Chianale J, Vollrath V, Wielandt AM et al. Fibrates induce mdr2 gene expression and biliary phospholipids secretion in the mouse. Biochem J 1996; 314: 781-6.
-
(1996)
Biochem J
, vol.314
, pp. 781-786
-
-
Chianale, J.1
Vollrath, V.2
Wielandt, A.M.3
-
39
-
-
24144496798
-
Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of,-cell differentiation and secretory function in the db/ db mouse model of diabetes
-
Kjorholt C, Akerfeldt MC, Biden TJ, Laybutt DR. Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of,-cell differentiation and secretory function in the db/db mouse model of diabetes. Diabetes 2005; 54: 2755-63.
-
(2005)
Diabetes
, vol.54
, pp. 2755-2763
-
-
Kjorholt, C.1
Akerfeldt, M.C.2
Biden, T.J.3
Laybutt, D.R.4
-
40
-
-
34249908931
-
Bezafibrate induces multidrug-resistance P-Glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice
-
Shoda J, Okada K, Inada Y et al. Bezafibrate induces multidrug-resistance P-Glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice. Hepatol Res 2007; 37: 548-56.
-
(2007)
Hepatol Res
, vol.37
, pp. 548-556
-
-
Shoda, J.1
Okada, K.2
Inada, Y.3
-
41
-
-
16644368576
-
Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4
-
Shoda J, Inada Y, Tsuji A et al. Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4. J Lipid Res 2004; 45: 1813-25.
-
(2004)
J Lipid Res
, vol.45
, pp. 1813-1825
-
-
Shoda, J.1
Inada, Y.2
Tsuji, A.3
-
42
-
-
0032479423
-
-
Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue- and inducer-specific manner. J Biol Chem 1998; 273: 16710-14.
-
(1998)
J Biol Chem
, vol.273
, pp. 16710-16714
-
-
Motojima, K.1
Passilly, P.2
Peters, J.M.3
Gonzalez, F.J.4
Latruffe, N.5
-
43
-
-
0033061409
-
Increased peroxisomal fatty acid,-oxidation and enhanced expression of peroxisome proliferator-activated receptor-α in diabetic rat liver
-
Asayama K, Sandhir R, Sheikh FG, Hayashibe H, Nakane T, Singh I. Increased peroxisomal fatty acid,-oxidation and enhanced expression of peroxisome proliferator-activated receptor-α in diabetic rat liver. Mol Cell Biochem 1999; 194: 227-34.
-
(1999)
Mol Cell Biochem
, vol.194
, pp. 227-234
-
-
Asayama, K.1
Sandhir, R.2
Sheikh, F.G.3
Hayashibe, H.4
Nakane, T.5
Singh, I.6
-
44
-
-
0034711185
-
Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators
-
Delerive P, Gervois P, Fruchart JC, Staels B. Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators. J Biol Chem 2000; 275: 36703-7.
-
(2000)
J Biol Chem
, vol.275
, pp. 36703-36707
-
-
Delerive, P.1
Gervois, P.2
Fruchart, J.C.3
Staels, B.4
-
45
-
-
36148934819
-
Life style-related diseases of the digestive system: Gene expression in nonalcoholic steatohepatitis patients and treatment strategies
-
Yoneda M, Endo H, Nozaki Y et al. Life style-related diseases of the digestive system: Gene expression in nonalcoholic steatohepatitis patients and treatment strategies. J Pharmacol Sci 2007; 105: 151-6.
-
(2007)
J Pharmacol Sci
, vol.105
, pp. 151-156
-
-
Yoneda, M.1
Endo, H.2
Nozaki, Y.3
-
46
-
-
34047199047
-
Bezafibrate regulates the expression and enzyme activity of 11β-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes
-
Nakano S, Inada Y, Masuzaki H et al. Bezafibrate regulates the expression and enzyme activity of 11β-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2007; 292: E1213-22.
-
(2007)
Am J Physiol Endocrinol Metab
, vol.292
-
-
Nakano, S.1
Inada, Y.2
Masuzaki, H.3
-
47
-
-
3042820278
-
Liver injury in the setting of steatosis: Crosstalk between adipokine and cytokine
-
Czaja MJ. Liver injury in the setting of steatosis: Crosstalk between adipokine and cytokine. Hepatology 2004; 40: 19-22.
-
(2004)
Hepatology
, vol.40
, pp. 19-22
-
-
Czaja, M.J.1
-
48
-
-
10744228583
-
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
-
Kamada Y, Tamura S, Kiso S et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003; 125: 1796-807.
-
(2003)
Gastroenterology
, vol.125
, pp. 1796-1807
-
-
Kamada, Y.1
Tamura, S.2
Kiso, S.3
-
49
-
-
0037221210
-
Peroxisome proliferator-activated receptor-β signaling contributes to enhanced proliferation of hepatic stellate cells
-
Hellemans K, Michalik L, Dittie A et al. Peroxisome proliferator-activated receptor-β signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology 2003; 124: 184-201.
-
(2003)
Gastroenterology
, vol.124
, pp. 184-201
-
-
Hellemans, K.1
Michalik, L.2
Dittie, A.3
-
50
-
-
33845788135
-
Intrahepatic insulin resistance in a murine model of steatohepa titis: Effect of PPARγ agonist pioglitazone
-
Leclercq IA, Lebrun VA, Starkel P, Horsmans YJ. Intrahepatic insulin resistance in a murine model of steatohepa titis: Effect of PPARγ agonist pioglitazone. Lab Invest 2007; 87: 56-65.
-
(2007)
Lab Invest
, vol.87
, pp. 56-65
-
-
Leclercq, I.A.1
Lebrun, V.A.2
Starkel, P.3
Horsmans, Y.J.4
-
51
-
-
33846253661
-
Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis
-
Ota T, Takamura T, Kurita S et al. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology 2007; 132: 282-93.
-
(2007)
Gastroenterology
, vol.132
, pp. 282-293
-
-
Ota, T.1
Takamura, T.2
Kurita, S.3
-
52
-
-
0842308111
-
Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient 1-amino acid-defined diet
-
Kawaguchi K, Sakaida I, Tsuchiya M, Omori K, Takami T, Okita K. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient 1-amino acid-defined diet. Biochem Biophys Res Commun 2004; 315: 187-95.
-
(2004)
Biochem Biophys Res Commun
, vol.315
, pp. 187-195
-
-
Kawaguchi, K.1
Sakaida, I.2
Tsuchiya, M.3
Omori, K.4
Takami, T.5
Okita, K.6
-
53
-
-
23944486588
-
The peroxisome proliferator-activated receptor-γ agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, 1-amino acid-defined diet
-
Uto H, Nakanishi C, Ido A et al. The peroxisome proliferator-activated receptor-γ agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, 1-amino acid-defined diet. Hepatol Res 2005; 32: 235-42.
-
(2005)
Hepatol Res
, vol.32
, pp. 235-242
-
-
Uto, H.1
Nakanishi, C.2
Ido, A.3
-
54
-
-
0034743328
-
y mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones
-
y mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. J Hepatol 2001; 35: 17-23.
-
(2001)
J Hepatol
, vol.35
, pp. 17-23
-
-
Bedoucha, M.1
Atzpodien, E.2
Boelsterli, U.A.3
-
55
-
-
0346689994
-
The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance
-
Rinella ME, Green RM. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 2004; 40: 47-51.
-
(2004)
J Hepatol
, vol.40
, pp. 47-51
-
-
Rinella, M.E.1
Green, R.M.2
|